U.S. Markets open in 7 hrs 1 min

New Strong Sell Stocks for August 3rd

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:

CAE Inc. CAE is a world leader in providing simulation and modeling technologies, and integrated training services. The Zacks Consensus Estimate for its current year earnings has been revised 1.3% downward over the last 30 days.

Dril-Quip, Inc. DRQ is one of the world's leading manufacturers of offshore drilling and production equipment. The Zacks Consensus Estimate for its current year earnings has been revised 31.6% downward over the last 30 days.

Freshpet, Inc. FRPT is a pet food company. The Zacks Consensus Estimate for its current year earnings has been revised 20% downward over the last 30 days.

Orchid Island Capital, Inc. ORC is a specialty finance company. The Zacks Consensus Estimate for its current year earnings has been revised 5.7% downward over the last 30 days.

PhaseBio Pharmaceuticals, Inc. PHAS is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 2.5% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
DrilQuip, Inc. (DRQ) : Free Stock Analysis Report
 
Freshpet, Inc. (FRPT) : Free Stock Analysis Report
 
CAE Inc (CAE) : Free Stock Analysis Report
 
Orchid Island Capital, Inc. (ORC) : Free Stock Analysis Report
 
PHASEBIO PHARMA (PHAS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.